Live Breaking News & Updates on Sosei Group Corporation|Page 8

Stay updated with breaking news from Sosei group corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sosei Heptares' partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults Seite 1

12.09.2023 - NBI-1117570 is an investigational, oral, muscarinic M1/M4 selective dual agonist discovered by Sosei Heptares that may have the potential to treat neurological and neuropsychiatric conditionsNBI-1117570 is the second compound to advance into . Seite 1 ....

United Kingdom , Sosei Heptares , Neurocrine Biosciences , Sosei Heptare , Eiryw Roberts , Matt Barnes , Neurocrine Biosciences Inc , Sosei Group Corporation The Company , Sosei Group Corporation , Chief Medical Officer , Heptares Therapeutics , Sosei Group Chart , Osei Group Kurs , Osei Group Aktie ,